Meta

Further, further on medicinal drugs and prices

Yale study finds post-approval safety issues with drugs and especially those that have been fast tracked.

This story in THE HINDU suggests that many advanced countries too have problems with pricing of drugs. But, I suppose that does not stop them from lobbying for their pharma companies with developing countries.